Live Breaking News & Updates on Summit Pharmaceuticals International Corporation

Stay updated with breaking news from Summit pharmaceuticals international corporation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

New CRISPR/Cas9 license agreement to advance disease model development

New CRISPR/Cas9 license agreement to advance disease model development
labmate-online.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from labmate-online.com Daily Mail and Mail on Sunday newspapers.

United States , Summit Pharmaceuticals International Corporation , Sumitomo Corporation , Elixirgen Scientific Inc , Genomics Ltd , Ricoh Company Ltd , Ricoh Company , Elixirgen Scientific , Pharmaceuticals International Corporation ,

Sumitomo Pharma takes license to CRISPR/Cas9 patent portfolio from ERS Genomics

/PRNewswire/ ERS Genomics Limited ("ERS") is pleased to confirm finalization of a license agreement with Sumitomo Pharma Co., Ltd. ("Sumitomo Pharma"). ....

Sumitomo Pharma , Emmanuelle Charpentier , Dara Odonnell , Eric Rhodes , Sumitomo Corporation , Summit Pharmaceuticals International Corporation , Pharmaceuticals International Corporation ,